AGP Executive Report
Last update: 6 hours agoHemp Regulation: Texas retailers will challenge the state’s smokable-hemp ban in court on December 8. The rules also sharply raised licensing fees and restrict hemp-derived THC products. Sleep and Cannabinoids: CBN sleep aids may offer modest benefits, but a new animal study linked repeated exposure to signs of physical dependence. Other coverage warns that long-term cannabis use may harm sleep quality. Medical Research: New York regulators approved a trial of oral THC for sciatica-related chronic pain, while a University of Regina team is studying CBD as a possible concussion treatment. Treatment Access: Illinois added two conditions to its medical cannabis eligibility list, and the FDA cleared a pathway for conditional approval of a cannabinoid drug for dogs with bone-cancer pain. Product Transparency: The Hemp Doctor says it now publishes independent lab certificates for its CBD and other product lines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
